Reply to H.J adams et al: "Is FDG-PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B-cell lymphoma?"

Affiliations

¹ Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
² Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
³ Division of Medical Oncology, British Columbia Cancer Agency Centre for Lymphoid Cancer and the University of British Columbia, Vancouver, BC, Canada.

Free article

Comment

Tarec Christoffer El-Galaly et al. Am J Hematol. 2016 Feb.

Free article

. 2016 Feb;91(2):E2-3.

doi: 10.1002/ajh.24239.

¹ Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
² Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
³ Division of Medical Oncology, British Columbia Cancer Agency Centre for Lymphoid Cancer and the University of British Columbia, Vancouver, BC, Canada.

No abstract available

Comment on

Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
El-Galaly TC, Villa D, Alzahrani M, Hansen JW, Sehn LH, Wilson D, de Nully Brown P, Loft A, Iyer V, Johnsen HE, Savage KJ, Connors JM, Hutchings M. El-Galaly TC, et al. Am J Hematol. 2015 Nov;90(11):1041-6. doi: 10.1002/ajh.24169. Am J Hematol. 2015. PMID: 26260224
Is FDG-PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B-cell lymphoma?
Adams HJ, Kwee TC. Adams HJ, et al. Am J Hematol. 2016 Feb;91(2):E1-2. doi: 10.1002/ajh.24241. Am J Hematol. 2016. PMID: 26572499 No abstract available.